Selenium in human mammary carcinogenesis: a case-cohort study

Area of Science:

• Epidemiology
• Nutritional Science
• Oncology

Background:

• Human mammary carcinogenesis involves various risk indicators.
• Selenium is a trace element with potential roles in cancer prevention.
• Prospective cohort studies are crucial for understanding long-term disease risk factors.

Purpose of the Study:

• To examine the association between plasma selenium levels and the risk of developing breast cancer.
• To determine if selenium concentration can serve as a predictive biomarker for human breast cancer.

Main Methods:

• A prospective cohort study involving 5162 healthy women on Guernsey (1967-1976).
• Collection of blood samples and questionnaires on risk factors.
• Measurement of plasma selenium levels in 46 breast cancer cases and 138 controls.
• Statistical analysis of selenium distribution quartiles and adjusted relative risks.

Main Results:

• Mean plasma selenium levels were 109 (28) µg/l in cases and 103 (22) µg/l in controls.
• The 95% confidence interval for the difference was -2 to 14 µg/l.
• Adjusted relative risks for breast cancer across selenium quartiles were 0.80, 0.79, 0.72, and 1.00.

Conclusions:

• Plasma selenium levels did not show a strong association with breast cancer risk in this cohort.
• Selenium was not identified as a significant indicator for predicting human breast cancer development.
• Further research may be needed to explore the complex relationship between selenium and mammary carcinogenesis.